Satoko Hirai
Amgen (United States)(US)
Publications by Year
Research Areas
Liver physiology and pathology, PI3K/AKT/mTOR signaling in cancer, Cancer Mechanisms and Therapy, Asymmetric Synthesis and Catalysis, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Discovery and Optimization of Triazolopyridazines as Potent and Selective Inhibitors of the c-Met Kinase(2008)139 cited
- → Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors(2009)56 cited
- → Discovery of (R)-6-(1-(8-Fluoro-6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one (AMG 337), a Potent and Selective Inhibitor of MET with High Unbound Target Coverage and Robust In Vivo Antitumor Activity(2016)34 cited
- → Sjögren's syndrome associated with thymoma(1996)8 cited
- Evaluation of cetirizine hydrochloride-based therapeutic strategy for chronic urticaria.(2008)
- → A descriptive analysis of producers’ attitudes toward biotechnology: a five‐state comparison(2006)2 cited
- → CLINICAL STATISTIC OBSERVATIONS OF INPATIENTS OF THE DEPARTMENT OF ORAL SURGERY DURING THE PAST 12 YEARS(1976)2 cited
- → Corrigendum to “Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors” [Bioorg. Med. Chem. Lett. 19 (2009) 6307](2009)2 cited
- → Dick Diver's Failure : Dramatic Aspects of Tender Is the Night(1993)
- The synthesis and applications of a biaryl-based asymmetric phosphine ligand(2005)